BioCryst Pharmaceuticals: Influenza, Human trials

The registry lists 10 Influenza, Human studies with BioCryst Pharmaceuticals as lead sponsor. 0 are open to participants now and 8 have results posted.

Phase 2 3Phase 3 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Safety, PK and Effectiveness of IV Peramivir in Elderly and Higher Risk Subjects With Uncomplicated InfluenzaCompletedNCT02635724Phase 3Results posted
• Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated InfluenzaCompletedNCT02369159Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to InfluenzaTerminatedNCT00958776Phase 3Results posted
• Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected InfluenzaCompletedNCT00957996Phase 3Results posted
• A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute InfluenzaCompletedNCT00705406Phase 2Results posted
• Intramuscular Peramivir in Subjects With Uncomplicated Acute InfluenzaTerminatedNCT00610935Phase 3Results posted
• Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening InfluenzaCompletedNCT00453999Phase 2Results posted
• Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.CompletedNCT00419263Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.WithdrawnNCT01224795Phase 3
• Intramuscular Peramivir for the Treatment of Uncomplicated InfluenzaWithdrawnNCT00486980Phase 3